GUJTHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Gujarat Themis Biosyn has submitted its Annual Secretarial Compliance Report for the financial year ending March 31, 2025, to BSE and NSE. The report, issued by practicing company secretary KRS and Co., confirms that the company has largely complied with SEBI regulations, circulars, and guidelines during the year. One non-compliance was flagged: a 41-day delay in implementing a bonus issue, which breached Regulation 295(1) of SEBI's ICDR Regulations, 2018. BSE imposed a fine of ₹9,72,000 (including 18% GST), which the company has accepted and already paid, calling the delay inadvertent and due to procedural and operational reasons. The matter stands closed, and the company has stated it will ensure adherence to timelines in the future.
This is a routine compliance filing with one resolved lapse that has already been financially settled. No material impact on shareholders or the stock is expected, as the fine is paid and the company is otherwise in good compliance standing.